Community/Retail

First of its kind therapy combines 2 existing medications to battling debilitating methamphetamine use disorder.

New treatment approach is designed to treat retracted blood clots, which form over extended periods of time and are especially dense.

The statement said lactating women should discuss the risks and benefits of the COVID-19 vaccine with their health care provider.

Regular exercise and sufficient sleep can help strengthen the response to the COVID-19 vaccine.

Pharmacy Times® interviewed Emily Cook, a partner with McDermott Will & Emery, on the release of the final 340B Administrative Dispute Resolution (ADR) Rule and what it may mean for pharmacies.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on how COVID-19 vaccinations has affected the day-to-day of pharmacies.

Multiple large-scale studies have suggested that menopause is a sex-specific risk factor for cognitive dysfunction independent of aging and other menopause symptoms, such as depression, anxiety, and hot flashes.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on Walgreens’ plans to provide access to COVID-19 vaccines among vulnerable populations in medically underserved communities.

Macrophages could be critical treatment targets because they could be infected by SARS-CoV-2 and can contribute to spreading the infection through the lung.

A new study suggests abnormal sleep architecture can be a predictor of stress.

The study authors note that COVID-19 disease processes could predispose patients to a higher burden of acute brain dysfunction.

B.1.1.7, or otherwise known as VOC 202012/01, may lead to a large increase in the number of COVID-19 cases in the United States and may become the dominant strain of the virus in the coming months.

Pharmacy Times® interviewed Chad Landmon, the chair of intellectual property and FDA practice groups at Axinn, Veltrop & Harkrider, on the potential impact President-elect Joseph Biden’s cabinet nominations may have on the pharmacy field in 2021.

The changes, finalized today, are generally effective for the 2022 plan year and will potentially lower enrollee cost sharing on some of the most expensive prescription drugs.

Recent surveys indicate that the proportion of the US population willing to be vaccinated for COVID-19 has fluctuated from 72% in May to 51% in September 2020.

The recommendations focus on dilution errors, vaccine and monoclonal antibody mix-ups, waste of doses, administering immunizations to the wrong age group, errors with scheduling the second dose, and allergic reactions.

In a statement by the APhA, Scott J. Knoer, executive vice president and CEO of APhA, noted the association’s support for this first step by the Biden administration on the road to recovery from the pandemic.

Although safety and efficacy have been proven, a few questions still remain about how long the vaccines will be effective and whether they prevent asymptomatic infection.

Participants with severe withdrawal symptoms were more likely to be younger, longtime and frequent users of cannabis, and to have worse mental health.

New research suggests immunosuppressants do not increase the risk of worse COVID-19 outcomes.

In a statement released by NCPA, the association explained that the current COVID-19 vaccination rollout in the country could be accelerated by working with community pharmacists.

This medicinal beverage was believed to be an effective treatment for hypothermia, which earned it regular passage on many of the early expeditions to the Arctic.

The single dose investigational vaccine being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson is a recombinant, replication-incompetent adenovirus serotype 26 vector encoding a stabilized SARS-CoV-2 spike protein.

The symptoms of depression in caregivers of patients with dementia exacerbates over time.

As new testing devices, therapies, and vaccines are approved for COVID-19, patients will be dependent on their health care providers for answers and education.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on the rollout of phase 1b and c of COVID-19 vaccinations at Walgreens pharmacies.

The analysis found that at least 38 minutes of moderate intensity exercise each day was associated with the lower risk, which is a little more than the current recommendations of at least 30 minutes a day, 5 days a week.

The new research shows that adolescents are 9 times more likely to receive a vaccine when providers introduce the topic to parents with a simple statement such as “your child is due for vaccines today,” as it results in a shorter vaccine discussion.